![](https://endpts.com/wp-content/uploads/2021/09/Roberto-Bellini-Bellus-Health-tile-scaled.jpg)
Roberto Bellini, Bellus Health CEO
Bellus soars on positive mid-stage readout for its Merck cough rival, despite a failure in atopic dermatitis
Do investors want the good news, or the bad news first? Bellus went with the good news, sharing that its chronic cough contender hit the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.